Lonsurf 15 MG-6.14 MG tablet 40S
Ended Awarded
- Contract number
- SPE2DB26FY1U8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,248
Award facts
- Contract value 100% obligated
- $10,248.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $10,248.32 and firm fixed pricing. The contract is non-set-aside and represents a competitively awarded delivery order, with an ultimate completion date of November 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor supplying medications and medical supplies to military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to deliver a wide range of pharmaceutical products across multiple therapeutic domains, from specialty medications to generic drugs and medical supplies. LONSURF is an oncology medication used in cancer treatment, reflecting AmerisourceBergen's role in providing specialized therapeutic medications to support defense health operations. As a child contract under the larger IDC vehicle, this delivery order exemplifies the company's position as a key supplier within DLA's pharmaceutical procurement structure.
Quick answers
Who was awarded contract SPE2DB26FY1U8?
SPE2DB26FY1U8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FY1U8 worth?
The government has obligated $10,248 on SPE2DB26FY1U8.
Is contract SPE2DB26FY1U8 an order under another contract?
Yes. SPE2DB26FY1U8 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1U8 competed?
The extent of competition for SPE2DB26FY1U8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award